Atrial fibrillation and the risk for myocardial infarction, all-cause mortality and heart failure: A systematic review and meta-analysisVidar Ruddox, Jan Erik Otterstad, Irene Sandven et al.|European Journal of Preventive Cardiology|2017Cited by 402
Effect of oral β-blocker treatment on mortality in contemporary post-myocardial infarction patients: a systematic review and meta-analysisMagnus Dahl Aarvik, Jan Erik Otterstad, Vidar Ruddox et al.|European Heart Journal - Cardiovascular Pharmacotherapy|2018Cited by 121
BEtablocker Treatment After acute Myocardial Infarction in revascularized patients without reduced left ventricular ejection fraction (BETAMI): Rationale and design of a prospective, randomized, open, blinded end point studyJohn Munkhaugen, Dan Atar, Svend Eggert Jensen et al.|American Heart Journal|2018Cited by 50
Medical and psychosocial factors and unfavourable low-density lipoprotein cholesterol control in coronary patientsJohn Munkhaugen, Einar Husebye, Elise Sverre et al.|European Journal of Preventive Cardiology|2017Cited by 47
The role of cardiac rehabilitation in secondary prevention after coronary eventsKari Peersen, Jan Erik Otterstad, John Munkhaugen et al.|European Journal of Preventive Cardiology|2017Cited by 46